Condition
Depersonalization Disorder
Total Trials
4
Recruiting
0
Active
0
Completed
3
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
33%
1 of 3 completed with results
Key Signals
1 with results100% success
Data Visualizations
Phase Distribution
4Total
Not Applicable (2)
P 2 (2)
Trial Status
Completed3
Withdrawn1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT02476435Not ApplicableCompletedPrimary
Depersonalization Disorder: Therapeutic Effect of Neuronavigated Repetitive Transcranial Stimulation
NCT02256085Phase 2WithdrawnPrimary
Treatment of Depersonalization Disorder With Repetitive Transcranial Magnetic Stimulation (rTMS)
NCT00529217Phase 2CompletedPrimary
Treatment of Depersonalization Disorder With Transcranial Magnetic Stimulation (TMS)
NCT00004446Not ApplicableCompletedPrimary
Study of Fluoxetine in Patients With Depersonalization Disorder
Showing all 4 trials